Related Experiment Video
Updated: Mar 14, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Artificial intelligence in oncology: Current status and possibilities (Review)
Abhavya Roy1, Apurva Bhoyar2, Ashok Ahirwar3
1University College of Medical Sciences, Guru Teg Bahadur Hospital, Delhi 110095, India.
Artificial intelligence (AI) is transforming oncology with advanced machine learning for better cancer diagnosis and personalized treatment. However, challenges like data bias and regulatory hurdles hinder its widespread clinical adoption.
Area of Science:
- Oncology
- Artificial Intelligence
- Machine Learning
Background:
- Artificial intelligence (AI) is increasingly integrated into oncology, impacting diagnostic accuracy, prognostication, and personalized treatment strategies.
- Machine learning (ML) and deep learning (DL) models, including convolutional neural networks (CNNs) and transformers, show significant promise in cancer research.
Purpose of the Study:
- To critically review current AI applications in oncology, covering imaging, digital pathology, outcome prediction, and treatment planning.
- To synthesize recent advancements and identify challenges hindering the clinical translation of AI in cancer care.
Main Methods:
- Review of contemporary literature on AI applications in various oncology domains.
- Analysis of machine learning and deep learning model performance in tasks like lesion detection, tumor grading, and survival prediction.
Main Results:
- AI models demonstrate expert-level or superior accuracy in specific oncological tasks, including image analysis and outcome prediction.
- Significant barriers to clinical implementation exist, such as dataset bias, limited generalizability, lack of standardization, interpretability issues, and regulatory hurdles.
Conclusions:
- AI holds immense potential to advance precision oncology and improve global cancer outcomes.
- Overcoming challenges through multidisciplinary collaboration, prospective validation, and ethical governance is crucial for realizing AI's full potential in cancer care.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

